Pancreaze Capsule, Delayed Release
Product Images NDC 62541-404

This text appears to be describing a medication called PANCREAZE in its delayed-release capsule form. The capsules contain three different enzymes: lipase, amylase, and protease, and are used to treat pancreatic problems. The text also includes dosage information and manufacturing details.*

This is a product description for PANCREAZE® delayed-release capsules used for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions. The capsules contain lipase, amylase, and protease enzymes, which aid in the digestion of fats, carbohydrates, and proteins. The text includes dosage instructions and storage recommendations for the medication. The lot number, expiration date, GTN, serial number, and 20 barcode are reserved in the background.*

PANCREAZE® is a medication presented in the form of delayed-release capsules that contain lipase, amylase and protease enzymes to support healthy digestion. The coverings of the microtablets are intended to prevent crushing or chewing. The capsules need to be stored in their original container and kept tightly closed to protect them from moisture. PANCREAZE® is manufactured by Nordmark Pharma Gt in Germany, and finished by VWUSLiC in California. Each capsule of PANCREAZE® contains Lipase 16,800 USP Units, Amylase 98,400 USP Units, and Protease 56,800 USP Units. Please follow the dosage by LIPASE UNITS and Dispense only with the accompanying medical guide to each patient.*

This is a product information sheet for the medication PANCREAZE® which contains pancrelipase in the form of delayed-release capsules. The capsules contain lipase, amylase, and protease enzymes. It is manufactured in Germany and the microtablets inside the capsules should not be crushed, chewed or opened. The medication should be stored in its original container after opening and kept tightly closed to protect from moisture. The prescribed dosage is dependent on the amount of lipase units.*

This appears to be a product description for PANCREAZE, a pancreatic enzyme replacement therapy used to help with digestion in individuals who have exocrine pancreatic insufficiency. It is a delayed-release capsule that should not be crushed and should be protected from moisture. The capsules contain microtablets coated to protect the enzyme content. Each capsule contains amylase and protease in specific units. The product is of German origin and is manufactured by Finenea.*

Pancreaze is a delayed-release capsule that contains amylase and protease, with each capsule containing 149,900 USP units and 97,300 USP units, respectively. These delayed-release capsules use enteric-coated pancrelipase microtablets sourced from pigs. To protect the enteric coating, the microtablets should not be crushed or chewed. This prescription-only medication should be stored in a dry place below 25°C and should be kept away from children. The medication guide should be dispensed to each patient along with the medication. The manufacturer is not mentioned.*